OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

How do I know if I actually need D3, based on lab tests?

Sep 8, 2026 · 4 sources used · OpenNeedle synthesis
The short version: the only lab test that tells you whether you need D3 is serum 25-hydroxyvitamin D, and the evidence for treating deficiency is strongest for bone outcomes, not for the vague benefits most supplement marketing claims.

The test you want is 25-hydroxyvitamin D, measured in ng/mL or nmol/L. That is the storage form that reflects your total body status. The evidence consistently shows that levels below 12 ng/mL are where fracture risk climbs sharply. In a pooled cohort of about 4,700 older adults, people under 30 nmol/L (about 12 ng/mL) had significantly higher risk of hip and major osteoporotic fractures within ten years, while people in the 30 to 74 nmol/L range were not at elevated risk compared to those above 75 nmol/L [7]. That is the key threshold. Below roughly 12 ng/mL, you have a real problem. Between 12 and 30 ng/mL, the evidence for benefit from supplementation is much weaker for hard outcomes.

The mega-trials back this up. Four large randomized trials of vitamin D in adults over 50 found no reduction in heart disease, cancer incidence, fractures, or falls in the general population [4]. The only consistent signal was a possible 13 to 17 percent reduction in cancer mortality, and benefits for bone density, arterial function, and lung function appeared mainly in people who were deficient at baseline [4]. So the question is not "should everyone take D3." It is "are you actually deficient?" If you are not below the deficiency threshold, the evidence says supplementation is unlikely to change your hard outcomes.

One more test matters if you are low: parathyroid hormone, or PTH. When vitamin D is deficient, PTH rises to pull calcium from bone. A 2025 study of about 1,000 patients found that a PTH above 40 pg/mL identified people with significantly lower vitamin D, lower calcium, and lower bone density [25]. In hip fracture patients, severe vitamin D deficiency with elevated PTH is common, and women are more likely than men to have a blunted PTH response [22]. If your 25(OH)D is low and your PTH is high, that is a stronger signal that supplementation is genuinely indicated.

Lab testWhat it tells youAction threshold
25-hydroxyvitamin DTotal body vitamin D statusBelow 12 ng/mL: clear deficiency
Parathyroid hormone (PTH)Whether deficiency is stressing your bonesAbove 40 pg/mL with low D: supplementation indicated

The honest bottom line: get the 25(OH)D test first. If it is below 12 ng/mL, supplementation is justified by the fracture evidence. If it is between 12 and 30, the evidence is mixed and depends on your age, bone health, and other risk factors. If it is above 30, the mega-trials say supplementation will not change your risk of heart disease, cancer, or falls. Do not supplement blindly. Test first, then decide.

My call: test 25-hydroxyvitamin D, and treat only if you are below about 12 ng/mL, with PTH as a supporting signal. Confidence: high for the deficiency threshold, moderate for the exact cutoff above which supplementation stops helping.

Keep digging

Sources used 4

  1. Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D? JBMR Plus (2021) narrative review Strong

    The review of seven recent vitamin D mega-trials (four published: CAPS, ViDA, VITAL, DO-HEALTH) finds no prevention of hard-disease endpoints such as CVD, cancer, fractures, or falls—aside from a possible 13–17% reduction in cancer mortality—while showing benefits for intermedia…

    DOI: 10.1002/jbm4.10459
  2. Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults Journal of Bone and Mineral Research (2012) primary study Strong

    In a pooled cohort of 4,749 U.S. adults aged 65+ from NHANES III and 2000-2004, lower serum 25-hydroxyvitamin D was significantly associated with increased risk of major osteoporotic fracture (linear) and hip fracture (quadratic) within 10 years of follow-up, but not beyond 10 y…

    DOI: 10.1002/jbmr.1828
  3. Parathyroid hormone response to severe vitamin D deficiency is sex associated: An observational study of 571 hip fracture inpatients The Journal of nutrition, health and aging (2013) Thin

    This observational study investigates the sex-associated differences in parathyroid hormone response to severe vitamin D deficiency in 571 hip fracture inpatients, revealing that women have a higher prevalence of functional hypoparathyroidism compared to men.

    DOI: 10.1007/s12603-012-0088-y
  4. Serum PTH ≥ 40 pg/mL as a Marker of Bone Fragility and Vitamin D Deficiency in Periodontitis Patients: Biochemical, Densitometric and Genetic Evidence Biomolecules (2025) primary study Strong

    In a cross-sectional study of 1038 periodontitis patients, a serum PTH threshold of 40 pg/mL identified individuals with significantly lower vitamin D, calcium, and bone mineral density, and ERα genetic variants were associated with elevated PTH, supporting PTH screening for ear…

    DOI: 10.3390/biom15111600

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question